Who
Paul Herendeen
Director
Company insider
Files Form 4 as: Director, Elanco Animal Health; EVP and CFO, Bausch Health Companies; Exec. V.P. and CFO, Zoetis; Exec. V.P. and CFO, Warner Chilcott.
In numbers
- Trades disclosed
- 92
- Buys
- 5
- Sells
- 16
- Bought
- $1.3M
- Sold
- $17.7M
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 21 Sep 2006
- Last trade
- 7 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 10 Aug 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $237K10,000 at $23.69 | filing |
| 7 Aug 2026filed 10 Aug 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $237K10,000 at $23.69 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 28 Nov 2025filed 2 Dec 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —10,314 at $0.00 | filing |
| 29 Nov 2024filed 3 Dec 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,169 at $0.00 | filing |
| 30 Nov 2023filed 4 Dec 2023 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —20,374 at $0.00 | filing |
| 30 Nov 2022filed 2 Dec 2022 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,649 at $0.00 | filing |
| 9 Sep 2022filed 9 Sep 2022 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $150K10,000 at $15.03 | filing |
| 30 Nov 2021filed 2 Dec 2021 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —7,307 at $0.00 | filing |
| 10 Mar 2021filed 10 Mar 2021 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $2.0M59,519 at $32.97 | filing |
| 8 Mar 2021filed 10 Mar 2021 | BHC Bausch Health Companiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —49,324 | filing |
| 8 Mar 2021filed 10 Mar 2021 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code M | —49,324 | filing |
| 8 Mar 2021filed 10 Mar 2021 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —50,518 at $0.00 | filing |
| 3 Mar 2021filed 5 Mar 2021 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —63,439 at $0.00 | filing |
| 3 Mar 2021filed 5 Mar 2021 | BHC Bausch Health Companiesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —91,684 at $0.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $495K15,755 at $31.42 | filing |
| 15 Sep 2020filed 16 Sep 2020 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $26K1,642 at $15.91 | filing |
News
No headline names them, or the companies they trade most, lately.